<DOC>
	<DOCNO>NCT01623193</DOCNO>
	<brief_summary>This study single centre pilot randomize trial compare all-blood cardioplegia dilute 4:1 blood cardioplegia cardiac surgery . The hypothesis all-blood cardioplegia associate less blood transfusion well cardiac function .</brief_summary>
	<brief_title>The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion Cardiac Surgery ? A Single Centre Pilot Study</brief_title>
	<detailed_description>This single centre randomize , double blind , 2 arm , parallel group pilot study compare all-blood cardioplegia 4:1 blood cardioplegia patient undergoing cardiac surgery . This pilot study support design large multicentre trial . Subjects undergoing cardiac surgery randomize receive either standard care ( 4:1 ) all-blood cardioplegia myocardial protection . Neither cardioplegia approach would consider investigational . Each use numerous cardiac surgical centre around world . The cardioplegia deliver use Quest medical MPS system Health Canada Approved device . Clinical endpoint evalauted ( rate blood transtransfusion , ICU stay , etcâ€¦ ) . In subset subject meet specific criterion , ventricular function evaluate operating room use CD Leycom INCA conductance catheter system .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>patient ( male female ) undergoing isolated coronary artery bypass grafting , isolate aortic mitral repair replacement , combine aortic mitral valve repair replacement coronary bypass graft reoperation , endocarditis , dialysis dependant renal failure , preoperative ECMO LVAD support , contraindication blood transfusion ( ie . Jehovah 's Witness ) , use irreversible antiplatelet ( ASA ) anticoagulant agent within 48h ( ie . plavix , dabigitran , GpIIb/IIIa inhibitor , argatroban ) .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Cardioplegia</keyword>
	<keyword>Blood transfusion</keyword>
	<keyword>Cardiac function</keyword>
	<keyword>Myocardial edema</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Valve disease</keyword>
</DOC>